The European Commission has appointed Phase Holographic Imaging, Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer. The €2.1 million grant finances a three-year research project which is coordinated by Malmö University and commercialized by Phase Holographic Imaging (PHI). Current methods for […]
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types Exclusive IP licensed from the University of Cambridge Geographically diversified, top-tier investor team includes key industry leaders to support early company development Cambridge, UK: Elpis BioMed, a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell […]
IsoPlexis will use four new NIH grants to advance research and development of immunotherapies to treat solid tumors, bone marrow disease, autoimmune diseases and infectious diseases. Branford, Conn.—IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology and the immune-based cancer treatment revolution, announced today that it has received […]
Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications. This novel product family will be on display from the 9th to the 10th of […]
PARIS—Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech […]
SAN FRANCISCO — Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with Harvard Biosciences. The https://www.baratron.com/ – photo distribution agreement covers Fluxion’s BioFlux™ and IonFlux™ platforms for sale to Harvard Bioscience’s customers in North America. Fluxion’s BioFlux system is […]
Award to Chinese Scientist Supports the Use of Various Molecular Approaches to Cancer Research SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Professor Jiandong Jiang has received an Agilent Thought Leader Award in support of his studies on cancer stem cells differentiation induced by natural products. “Cancer is a chronic disease generated […]
Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM), a unit of the Helsinki Institute of Life Science at the University of Helsinki today announced they are extending their personalized medicine collaboration to include multiple new applications that leverage the unique capabilities of Labcyte’s Echo® Liquid Handler and Access™ Automation platform. The organizations first […]
Expanded data acquisition and analysis capabilities added to gold-standard software for patch-clamp experiments SUNNYVALE, Calif. Molecular Devices, LLC, a leader in protein and cell biology technologies, announced the launch of the newest generation of its widely-used data acquisition and analysis software for patch-clamp electrophysiology, pCLAMP™ Software Suite Version 11 today. Among many new features, this […]
America’s Seed Fund Powered by NSF Provides Funding for R&D; Helps small businesses move innovations out of the lab and into the market StabiLux Biosciences has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase II grant for $600,000 to commercialize innovative technology by conducting research and development (R&D) work on […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
